Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Finding About Pathogen in Newborns, May Aid Vaccine Development

21.07.2004


A previously unrecognized molecular structure on the surface of the human bacterial pathogen Group B Streptococcus (GBS) – the most common cause of sepsis and meningitis in newborn infants – is described by researchers at the University of California, San Diego (UCSD) School of Medicine in Proceedings of the National Academy of Sciences published online the week of July 19, 2004.

The new discovery has important implications for understanding the mechanism of infection and the design of vaccines to boost human immunity against this potentially devastating pathogen. For example, potential GBS vaccines currently in clinical trials have been developed without this new knowledge, which could possibly impact their effectiveness.

The findings are a collaborative effort between the laboratories of senior author Ajit Varki, M.D., UCSD professor of medicine and cellular and molecular medicine, and co-director of the UCSD Glycobiology Research and Training Center (GRTC), and Victor Nizet, M.D., associate professor of pediatrics, UCSD Division of Infectious Diseases and an attending physician at Children’s Hospital, San Diego. The two groups have been studying the phenomenon in which certain bacterial pathogens coat their surfaces with a thick capsule made of carbohydrate sugars similar to those found on the surface of human cells. In the case of GBS, the bacterial surface capsule contains sialic acid, a sugar that is also displayed prominently on the surface of all cells in the human body. It is believed that GBS uses sialic acid as a form of “molecular mimicry”, where the bacteria disguises itself to look more like human cells and thereby avoids recognition by the immune system.



Using the sophisticated analytical techniques of the UCSD GRTC facility, graduate student Amanda Lewis discovered that the sialic acid of the GBS capsule contained a chemical modification known as O-acetylation, that had been previously overlooked in more than 30 years of published investigations. O-acetylation was detected in every one of 10 different GBS strains examined, with the overall level of modified sialic acid ranging from 5 percent to 55 percent.

“There are a number of reasons why previous researchers have missed this biochemical structure,” said Varki. “Older detection instruments may have been less sensitive, and some of the harsh chemical treatments employed to purify the capsule are known to destroy O-acetylation.”

He added that “since similar chemical treatments are commonly used to isolate GBS capsule for immunization studies, GBS vaccines in development are missing this component of the true or ‘native’ surface structure of the bacteria.”

In other bacterial pathogens where O-acetylation of surface sugars has been studied, it has been shown that the immune system is able to recognize and generate antibodies that specifically react with the O-acetyl modification. In the case of GBS, this possibility is particularly intriguing.

Varki noted that “an unmodified sialic acid-containing structure resembling the GBS capsule sugar, is present on the surface of all human cells; however, an O-acetylated form of this sugar has never, so far, been reported in humans”.

“This observation may have particular relevance for vaccine design,” Nizet added, “since the elimination of O-acetylation in a GBS vaccine potentially destroys a unique biochemical target for immune protection, inadvertently creating a vaccine antigen that more closely resembles normal human tissue structures”.

The discovery of the UCSD group has implications beyond vaccine design, and may also shed new light on the basic biology of the GBS infection. In previous studies, the presence or absence of O-acetylation on sialic acid has been shown to have important effects on the way the sugar can interact with molecules of the immune system such as antibodies and complement. The researchers are currently investigating whether GBS bacteria may use O-acetylation to vary their surface structure and create a “moving target” which is difficult for the human immune system to recognize.

It is estimated that 20 to 30 percent of women of childbearing age are asymptomatic carriers of GBS on their vaginal mucosal surface. Newborns can become infected with GBS that invade through the placenta to initiate infection in the womb, or alternatively, during delivery by exposure to contaminated vaginal fluids. Despite extensive screening of pregnant women and antibiotic prophylaxis during labor, it is estimated that approximately 3,600 newborns develop invasive GBS infections annually in the United States. In addition to neonatal disease, GBS is increasingly associated with serious infections in adult populations such as pregnant women, diabetics, and the elderly.

“The presence of sialic acid in the GBS surface capsule has long been recognized as a critical virulence factor in disease progression,” said Nizet. “A full appreciation of its biochemical complexity will be critical for development of GBS therapeutic or preventative strategies that target this molecule.”

The study was supported by grants to Varki from the National Institutes of Health (NIH) and to Nizet from the Edward J. Mallinckrodt, Jr. Foundation.

| newswise
Further information:
http://www.ucsd.edu
http://cmm.ucsd.edu/varki/biography.html

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Solar Collectors from Ultra-High Performance Concrete Combine Energy Efficiency and Aesthetics

16.01.2017 | Trade Fair News

3D scans for the automotive industry

16.01.2017 | Automotive Engineering

Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs

16.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>